Skip to Main Content

Paper Details

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
Clin Cancer Res
8
2022
ERBB2, GI cancer, HER2, MBOT, MOC, MOCs, Ovarian Tumor, TAGLN, THBS2, gastrointestinal (GI) metastases, genes, lower GI tumors, mRNA, mucinous borderline ovarian tumors, mucinous ovarian carcinoma, mucinous ovarian tumors, patients, upper GI, upper and lower gastrointestinal tumors
Author NameAffiliation
Kylie L GorringePeter MacCallum Cancer Centre
Kylie L GorringeThe University of Melbourne
Derek S ChiuUniversity of British Columbia, and Vancouver General Hospital
Michael S AnglesioUniversity of British Columbia, and Vancouver General Hospital
Michael S AnglesioUniversity of British Columbia
Michael S AnglesioUniversity of British Columbia, and Vancouver General Hospital
Michael S AnglesioUniversity of British Columbia
Holly R HarrisFred Hutchinson Cancer Center
Holly R HarrisUniversity of Washington
Joellen M SchildkrautRollins School of Public Health, Emory University
Andrew BerchuckDuke University Medical Center
Kara L Cushing-HaugenFred Hutchinson Cancer Center
Jennifer AlsopUniversity of Cambridge
David D L BowtellPeter MacCallum Cancer Centre
David D L BowtellThe University of Melbourne
David D L BowtellPeter MacCallum Cancer Centre
David D L BowtellThe University of Melbourne
Alison BrandThe University of Sydney
Alison BrandWestmead Hospital
James D BrentonCancer Research UK Cambridge Institute, University of Cambridge
Ian G CampbellPeter MacCallum Cancer Centre
Ian G CampbellThe University of Melbourne
Cezary CybulskiInternational Hereditary Cancer Center, Pomeranian Medical University
Cyril B GilksUniversity of British Columbia
Paul HarnettThe University of Sydney
Paul HarnettCrown Princess Mary Cancer Centre, Westmead Hospital
Mercedes Jimenez-LinanAddenbrooke's Hospital
Catherine J KennedyThe University of Sydney
Catherine J KennedyThe Westmead Institute for Medical Research
Catherine J KennedyWestmead Hospital
Jennifer M KoziakAlberta Health Services-Cancer Care
Jenny LesterDavid Geffen School of Medicine, University of California at Los Angeles
Jan LubinskiInternational Hereditary Cancer Center, Pomeranian Medical University
Jan LubinskiInternational Hereditary Cancer Center, Pomeranian Medical University
Janusz MenkiszakPomeranian Medical University
Sandra OrsulicDavid Geffen School of Medicine, University of California at Los Angeles
Celeste Leigh PearceUniversity of Michigan School of Public Health ann arbor
Celeste Leigh PearceKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Celeste Leigh PearceUniversity of Michigan School of Public Health ann arbor
Celeste Leigh PearceKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
John V PearsonQIMR Berghofer Medical Research Institute
John V PearsonQIMR Berghofer Medical Research Institute
Malcolm C PikeKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Malcolm C PikeMemorial Sloan-Kettering Cancer Center
Malcolm C PikeKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Malcolm C PikeMemorial Sloan-Kettering Cancer Center
Helen SteedUniversity of Alberta
Helen SteedAlberta Health Services
Robyn L WardThe University of Sydney
Robyn L WardThe University of Sydney
  • 1 - 50

Datasets